vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and FORWARD AIR CORP (FWRD). Click either name above to swap in a different company.

FORWARD AIR CORP is the larger business by last-quarter revenue ($631.2M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). FORWARD AIR CORP runs the higher net margin — -4.5% vs -10.1%, a 5.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -0.3%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 7.9%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Forward Air Corp is a leading North American asset-light logistics and transportation provider. It offers core services including expedited less-than-truckload freight delivery, final-mile logistics, intermodal transport, warehousing, and supply chain solutions, serving key sectors such as e-commerce, retail, manufacturing, and automotive across the U.S., Canada, and Mexico.

CLOV vs FWRD — Head-to-Head

Bigger by revenue
FWRD
FWRD
1.3× larger
FWRD
$631.2M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+45.0% gap
CLOV
44.7%
-0.3%
FWRD
Higher net margin
FWRD
FWRD
5.6% more per $
FWRD
-4.5%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
7.9%
FWRD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
FWRD
FWRD
Revenue
$487.7M
$631.2M
Net Profit
$-49.3M
$-28.3M
Gross Margin
Operating Margin
-10.1%
-0.5%
Net Margin
-10.1%
-4.5%
Revenue YoY
44.7%
-0.3%
Net Profit YoY
-123.2%
22.2%
EPS (diluted)
$-0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
FWRD
FWRD
Q4 25
$487.7M
$631.2M
Q3 25
$496.6M
$631.8M
Q2 25
$477.6M
$618.8M
Q1 25
$462.3M
$613.3M
Q4 24
$337.0M
$632.8M
Q3 24
$331.0M
$655.9M
Q2 24
$356.3M
$643.7M
Q1 24
$346.9M
$541.8M
Net Profit
CLOV
CLOV
FWRD
FWRD
Q4 25
$-49.3M
$-28.3M
Q3 25
$-24.4M
$-16.3M
Q2 25
$-10.6M
$-12.6M
Q1 25
$-1.3M
$-50.6M
Q4 24
$-22.1M
$-36.4M
Q3 24
$-9.2M
$-73.4M
Q2 24
$7.4M
$-645.4M
Q1 24
$-19.2M
$-61.7M
Gross Margin
CLOV
CLOV
FWRD
FWRD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
FWRD
FWRD
Q4 25
-10.1%
-0.5%
Q3 25
-4.9%
2.4%
Q2 25
-2.2%
3.2%
Q1 25
-0.3%
0.8%
Q4 24
-6.4%
12.0%
Q3 24
-2.7%
3.5%
Q2 24
2.0%
-170.2%
Q1 24
-6.5%
-12.1%
Net Margin
CLOV
CLOV
FWRD
FWRD
Q4 25
-10.1%
-4.5%
Q3 25
-4.9%
-2.6%
Q2 25
-2.2%
-2.0%
Q1 25
-0.3%
-8.3%
Q4 24
-6.6%
-5.8%
Q3 24
-2.8%
-11.2%
Q2 24
2.1%
-100.3%
Q1 24
-5.5%
-11.4%
EPS (diluted)
CLOV
CLOV
FWRD
FWRD
Q4 25
$-0.90
Q3 25
$-0.52
Q2 25
$-0.41
Q1 25
$-1.68
Q4 24
$-1.69
Q3 24
$-2.66
Q2 24
$-23.47
Q1 24
$-2.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
FWRD
FWRD
Cash + ST InvestmentsLiquidity on hand
$78.3M
$106.0M
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$308.7M
$113.3M
Total Assets
$541.0M
$2.7B
Debt / EquityLower = less leverage
14.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
FWRD
FWRD
Q4 25
$78.3M
$106.0M
Q3 25
$140.4M
Q2 25
$95.1M
Q1 25
$116.3M
Q4 24
$194.5M
$104.9M
Q3 24
$288.0M
$136.6M
Q2 24
$254.8M
$84.9M
Q1 24
$208.3M
$152.0M
Total Debt
CLOV
CLOV
FWRD
FWRD
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$1.7B
Stockholders' Equity
CLOV
CLOV
FWRD
FWRD
Q4 25
$308.7M
$113.3M
Q3 25
$340.9M
$139.8M
Q2 25
$344.2M
$151.8M
Q1 25
$336.1M
$154.6M
Q4 24
$341.1M
$201.7M
Q3 24
$342.2M
$226.1M
Q2 24
$324.9M
$283.8M
Q1 24
$292.5M
$926.1M
Total Assets
CLOV
CLOV
FWRD
FWRD
Q4 25
$541.0M
$2.7B
Q3 25
$559.7M
$2.8B
Q2 25
$575.0M
$2.8B
Q1 25
$583.7M
$2.8B
Q4 24
$580.7M
$2.8B
Q3 24
$653.0M
$3.1B
Q2 24
$674.2M
$3.1B
Q1 24
$671.8M
$4.0B
Debt / Equity
CLOV
CLOV
FWRD
FWRD
Q4 25
14.89×
Q3 25
12.05×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
1.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
FWRD
FWRD
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
FWRD
FWRD
Q4 25
$-66.9M
Q3 25
$12.1M
$52.7M
Q2 25
$5.4M
Q1 25
$-16.3M
$27.6M
Q4 24
$34.8M
$-23.2M
Q3 24
$50.0M
$51.2M
Q2 24
$44.8M
$-45.2M
Q1 24
$25.9M
$-51.7M
Free Cash Flow
CLOV
CLOV
FWRD
FWRD
Q4 25
$-69.0M
Q3 25
$11.4M
$48.6M
Q2 25
$4.8M
Q1 25
$-16.5M
$15.7M
Q4 24
$33.3M
$-30.5M
Q3 24
$49.6M
$40.7M
Q2 24
$44.4M
$-59.6M
Q1 24
$25.5M
$-56.7M
FCF Margin
CLOV
CLOV
FWRD
FWRD
Q4 25
-14.1%
Q3 25
2.3%
7.7%
Q2 25
1.0%
Q1 25
-3.6%
2.6%
Q4 24
9.9%
-4.8%
Q3 24
15.0%
6.2%
Q2 24
12.5%
-9.3%
Q1 24
7.3%
-10.5%
Capex Intensity
CLOV
CLOV
FWRD
FWRD
Q4 25
0.4%
1.3%
Q3 25
0.1%
0.7%
Q2 25
0.1%
0.8%
Q1 25
0.0%
1.9%
Q4 24
0.5%
1.1%
Q3 24
0.1%
1.6%
Q2 24
0.1%
2.2%
Q1 24
0.1%
0.9%
Cash Conversion
CLOV
CLOV
FWRD
FWRD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

FWRD
FWRD

Omni Logistics Segment$359.8M57%
Network$183.9M29%
Intermodal Segment$50.2M8%
Truckload$41.6M7%

Related Comparisons